期刊文献+

XAGE-1b在肝癌增殖侵袭中的生物学作用

The Proliferation and Invasion Effect of XAGE-1b in Hepatocellular Carcinoma
下载PDF
导出
摘要 目的探讨XAGE-1b在肝癌细胞株中的表达与增殖侵袭的关系。方法运用荧光定量PCR检测3株肝癌细胞株XAGE-1b内源性表达情况,选取内源性表达量较高的1株细胞株进行功能实验。运用XAGE-1b干扰片段转染肝癌细胞株,荧光定量PCR检测其转染效率;运用CCK8细胞增殖实验、Boyden小室细胞侵袭实验观察肝癌细胞株体外增殖及侵袭情况。结果XAGE-1b干扰载体转染肝癌细胞株后,其XAGE-1b的mRNA表达下调(P<0.05);干扰XAGE-1b肝癌细胞体外增殖、侵袭能力下降(P<0.05,P<0.05)。结论XAGE-1b表达下调抑制肝癌细胞体外增殖及侵袭能力,初步证实XAGE-1b在肝癌增殖侵袭中发挥重要作用。 Objective To investigate the relationship between the expression of XAGE-1b and proliferation and invasion in hepatocellular carcinoma(HCC)cell lines.Methods The endogenous expression of XAGE-1b in three HCC cell lines was detected by QPCR.One cell line with the highest endogenous expression was selected for the experiment.HCC cell line was infected by XAGE-1b interference vector,and the interference efficiency was detected by QPCR.CCK8 cell proliferation assay and Boyden chamber invasion assay were used to observe the proliferation and invasion of HCC cell lines in vitro.Results The expression of XAGE-1b was down-regulation by QPCR after transfection in the HCC cell(P<0.05),the ability of proliferation and invasion were down-regulation in vitro(P<0.05,P<0.05).Conclusion Down regulation of XAGE-1b expression inhibits the proliferation and invasion of HCC cells in vitro,XAGE-1b plays an important role in the proliferation and invasion of HCC.
作者 门慧 谈顺 MEN Hui;TAN Shun(Haikou Affiliated Hospital of Central South University,Haikou,570208)
出处 《实用癌症杂志》 2021年第5期697-700,共4页 The Practical Journal of Cancer
关键词 XAGE-1b 肝癌 增殖 侵袭 XAGE-1b Hepatocellular carcinoma Proliferation Invasion
  • 相关文献

参考文献9

二级参考文献64

  • 1叶定伟.前列腺癌的流行病学和中国的发病趋势[J].中华外科杂志,2006,44(6):362-364. 被引量:168
  • 2周清,郭爱林,安社娟,徐崇锐,杨素清,吴一龙.XAGE-1b基因在非小细胞肺癌中的表达及与临床特点的相关性研究[J].南方医科大学学报,2007,27(7):966-968. 被引量:4
  • 3Simpson AJ, Caballero OL, Jungbluth A, et al. Cancer/testis antigens, gametogenesis and cancer. Nat Rev Cancer, 2005, 5(8): 615-625.
  • 4Zendman AJ, Van Kraats AA, Weidle UH, et al. The XAGE family of cancer/testis-associated genes: alignment and expression profile in normal tissues, melanoma lesions and Ewing's sarcoma. Int J Cancer, 2002, 99(3): 361-369.
  • 5Egland KA, Kumar V, Duray P, et al. Characterization of overlapping XAGE-1 transcripts encoding a cancer testis antigen expressed in lung, breast, and other types of cancers. Mol Cancer Ther, 2002, 1(7): 441-450.
  • 6Marchand M, van Baren N, Weynants P, et al. Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1. Int J Cancer, 1999, 80(2): 219-230.
  • 7Bender A, Karbach J, Neumann A, et al. LUD 00-009: phase 1 study of intensive course immunization with NY-ESO-1 peptides in HLA-A2 positive patients with NY-ESO-1-expressing cancer. Cancer Immun, 2007, 7: 16.
  • 8Odunsi K, Q jan F, Matsuzaki J, et al. Vaccination with an NY-ESO-1 peptide of HLA class Ⅰ/Ⅱ specificities induces integrated humoral and T cell responses in ovarian cancer. Proc Natl Acad Sci USA, 2007, 104(31): 12837-12842.
  • 9Tajima K, Obata Y, Tamaki H, et al. Expression of cancer/testis (CT) antigens in lung cancer. Lung Cancer, 2003, 42(1): 23-33.
  • 10Nakagawa K, Noguchi Y, Uenaka A, et aI. XAGE-1 expression in non-small cell lung cancer and antibody response in patients. Clin Cancer Res, 2005, 11(15): 5496-5503.

共引文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部